Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Johnson Service Group eyes main list as profits, sales jump

(Sharecast News) - Johnson Service Group said it was considering moving to London Stock Exchange's main market on Tuesday, as it posted a jump in full-year earnings. The Aim-listed firm, which provides textiles rental and cleaning services, confirmed in a brief statement that it was considering the switch, but said it wanted to talk to its larger shareholders before providing a further update.

JSG first joined the London market in 1958 but transferred to Aim in 2008.

The update came as Johnson posted figures for the year to December end. Revenues rose 10.3% at £513.4m while adjusted pre-tax profits rose 23.1% at £54.8m.

On a statutory basis, operating profits jumped 25.5% at £54.7m.

In the hotel, restaurant and catering linen division, revenues increased 15.0% to £371.2m, boosted by both higher prices and volumes. In workwear, revenues were largely flat at £142.2m.

The firm also acquired rival Empire Linen Services during the year, in a £20.6m deal, and said it would continue to pursue acquisition opportunities.

Peter Egan, chief executive, said: "In line with our inorganic growth strategy, we continue to seek out and acquire earnings enhancing businesses which complement our existing geographic coverage.

"Our scale, expertise and operational excellence mean that we are well-placed to capitalise on opportunities and, accordingly, the board remains confident about delivering another year of progress in 2025."

As at 1400 GMT, shares in Johnson were up 11% at 146.8p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.